In recent years, healthcare markets such as pharmaceuticals, medical devices, and regenerative medicines, have experienced various technological breakthroughs, and these innovations are expected to establish a new market in the near future. In these markets, government regulations, research and development (R&D) incentives, and price regulations play a major role in promoting innovations. The objective of this project is to understand the impact of health-related policies on innovations. For example, we study pharmaceutical R&D on rare diseases in Japan by empirically examining the impact of health policies on innovation activities. A comparison to similar policies in foreign countries will also be made.
April 1, 2014 - March 31, 2016